The global dermatophytic onychomycosis (DO) therapeutics market was valued at US$ 3.1 billion by the end of 2015, of which North America was the largest market accounting for over 43% revenue share and expected to a compound annual growth rate (CAGR) of 9.2% until 2021 (Market data was collected at 2016).
The Competition:Laser companies claiming the treatment of toenail fungusPharmaceutical Companies with Oral Anti-fungal TreatmentsPharmaceutical Companies with Topical Anti-fungal treatments
ToeFX Competitive Advantage
All Photos on this page are copyright to ToeFX
Consider ToeFX's competative advantages!
To learn more please contact us with any questions or subcribe for our updates.